Trials / Withdrawn
WithdrawnNCT05515419
Allogeneic Cord Blood for Neurological Diseases in Adults
Allogeneic Cord Blood in the Treatment of Neurological Diseases in Adults
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The Medical Pavilion Bahamas · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood therapy for adult patients with neurological diseases.
Detailed description
Neurological diseases such as stroke or spinal cord injuries are very common etiologies causing disability in developed countries. Cord blood possess various stem and progenitor cells, as well as their secreted regenerative factors, and is known to repair injured brain. The investigators clinical research aims to determine the safety and efficacy of allogeneic Umbilical Cord Blood for adult patients with neurological diseases such as stroke and spinal cord injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Allogeneic cord blood treatment | Allogeneic cord blood treatment |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-09-30
- Completion
- 2026-11-30
- First posted
- 2022-08-25
- Last updated
- 2025-09-10
Source: ClinicalTrials.gov record NCT05515419. Inclusion in this directory is not an endorsement.